Summary
This prediction ended on 01.11.22 with a price of €16.86. The prediction closed with a disappointing performance of 11.64%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
GSK plc | 0.694% | 0.694% | 12.833% |
iShares Core DAX® | -3.033% | -0.013% | 11.953% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% |
According to BiotechBee what are the pros and cons of GSK plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread GlaxoSmithKline plc diskutieren
Sell mit Kursziel 10,0
In the thread Trading GlaxoSmithKline plc
Sell beendet